Frequency of Obstructive Sleep Apnea in Patients With Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis and Its Association With Clinical Findings
- PMID: 38283519
- PMCID: PMC10821713
- DOI: 10.7759/cureus.51224
Frequency of Obstructive Sleep Apnea in Patients With Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis and Its Association With Clinical Findings
Abstract
Objective: This study was designed to assess obstructive sleep apnea (OSA) in adult patients with cystic fibrosis (CF) and non-CF bronchiectasis (BE) and to relate it with clinical characteristics.
Methods: Thirty-five CF (27 years) and 35 non-CF (24 years) BE patients were included. Demographic characteristics, medications, comorbidities, BMI, dyspnea scales, pulmonary functions, sputum cultures, exacerbations, and hospitalizations were recorded. The Epworth Sleepiness Scale (ESS) questionnaire was filled and polysomnography was performed for each patient.
Results: ESS scores did not show any significant difference between CF and non-CF BE patients. Thirty-seven (53%) of all patients had OSA. There was no significant difference in OSA risk between CF and non-CF BE patients (54% vs 51%, respectively). Male gender was found to be a risk factor for OSA (68% of males vs 41% of females, respectively, p:0.026). Total sleep time, sleep efficiency, sleep latency, time spent awake after falling asleep, oxygen desaturation index, apnea-hypopnea-index (AHI), AHI in the supine position, and rapid eye movement phase did not show any significant difference between CF and non-CF patients. CF patients had significantly lower mean oxygen saturation (p:0.001) and lowest oxygen saturation (p:0.0024) levels and higher heart rate (p:0.02) compared to non-CF BE patients. Multiple logistic regression analysis of all patients revealed male gender and disease duration as risk factors for OSA (p:0.023 and p:0.041 respectively).
Conclusion: It is remarkable that more than half of the patients in both CF and non-CF bronchiectasis groups had OSA. Male gender and disease duration were found as risk factors for OSA.
Keywords: clinical characteristics; cystic fibrosis (cf); disease duration; non-cf bronchiectasis; obstructive sleep apnoea.
Copyright © 2023, Vezir et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
[Analysis of risk factors and consequences for concurrent obstructive sleep apnea in chronic obstructive pulmonary disease patients].Zhonghua Jie He He Hu Xi Za Zhi. 2019 Nov 12;42(11):832-837. doi: 10.3760/cma.j.issn.1001-0939.2019.11.009. Zhonghua Jie He He Hu Xi Za Zhi. 2019. PMID: 31694093 Chinese.
-
Continuous Positive Airway Pressure vs Mandibular Advancement Devices in the Treatment of Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis.Cureus. 2022 Jan 31;14(1):e21759. doi: 10.7759/cureus.21759. eCollection 2022 Jan. Cureus. 2022. PMID: 35251830 Free PMC article. Review.
-
Obstructive sleep apnea and nocturnal hypoxemia in adult patients with cystic fibrosis.BMC Pulm Med. 2022 Nov 28;22(1):446. doi: 10.1186/s12890-022-02243-0. BMC Pulm Med. 2022. PMID: 36437445 Free PMC article.
-
Gender differences in clinical manifestations and polysomnographic findings in Chinese patients with obstructive sleep apnea.Sleep Breath. 2020 Sep;24(3):1019-1026. doi: 10.1007/s11325-019-01943-y. Epub 2019 Oct 23. Sleep Breath. 2020. PMID: 31646422
-
Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090. doi: 10.1002/14651858.CD011090.pub2. Cochrane Database Syst Rev. 2015. PMID: 26171909 Review.
References
-
- Bronchiectasis imaging (Article in French) Chassagnon G, Brun AL, Bennani S, Chergui N, Freche G, Revel MP. Rev Pneumol Clin. 2018;74:299–314. - PubMed
-
- Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Aliberti S, Goeminne PC, O'Donnell AE, et al. Lancet Respir Med Mar. 2022;10:298–306. - PubMed
-
- Bronchiectasis. Magis-Escurra C, Reijers MH. https://pubmed.ncbi.nlm.nih.gov/25715965/ BMJ Clin Evid Feb. 2015;2015:1507. - PMC - PubMed
-
- Cystic fibrosis. Radlović N. https://pubmed.ncbi.nlm.nih.gov/22650116/ Srp Arh Celok Lek. 2012;140:244–249. - PubMed
LinkOut - more resources
Full Text Sources